Access the full text.
Sign up today, get DeepDyve free for 14 days.
KK Sahu, S Ailawadhi, N Malvik, J Cerny (2021)
Challenges of cellular therapy during the COVID-19 pandemicAdv Exp Med Biol, 1318
M Tagliamento, F Spagnolo, F Poggio (2020)
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakEur J Clin Invest, 50
MG Thompson, JL Burgess, AL Naleway (2021)
Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers - eight U.S. Locations, December 2020-March 2021Morb Mortal Wkly Rep, 70
A Brodziak, D Sigorski, M Osmola (2021)
Attitudes of patients with cancer towards vaccinations-results of online survey with special focus on the vaccination against COVID-19Vaccines, 9
A Yusuf, D Sarfati, CM Booth (2021)
Cancer and COVID-19 vaccines: a complex global pictureLancet Oncol
NH Schultz, IH Sørvoll, AE Michelsen (2021)
Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccinationN Engl J Med
CD Lehman, LR Lamb, HA D’Alessandro (2021)
Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approachAJR Am J Roentgenol
(Bussel JB, Connors JM, Cines DB, et al. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia). https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia. Accessed 26 May 2021.)
Bussel JB, Connors JM, Cines DB, et al. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia). https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia. Accessed 26 May 2021.Bussel JB, Connors JM, Cines DB, et al. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia). https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia. Accessed 26 May 2021., Bussel JB, Connors JM, Cines DB, et al. Thrombosis with thrombocytopenia syndrome (also termed vaccine-induced thrombotic thrombocytopenia). https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia. Accessed 26 May 2021.
KS Saini, HB de Las, R Plummer (2020)
Reimagining global oncology clinical trials for the postpandemic era: a call to armsJCO Glob Oncol, 6
MF Osuchowski, MS Winkler, T Skirecki (2021)
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entityLancet Respir Med
JD Siqueira, LR Goes, BM Alves (2021)
SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversityVirus Evol, 7
KS Saini, C Lanza, M Romano (2020)
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathyBr J Cancer, 123
M Leclerc, S Maury (2021)
A rationale to prioritise vaccination of HSCT patients against COVID-19Lancet Haematol, 8
H Zhang, H Han, T He (2021)
Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysisJ Natl Cancer Inst, 113
B Waissengrin, A Agbarya, E Safadi, H Padova, I Wolf (2021)
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitorsLancet Oncol
MC Garassino, M Vyas, EGE de Vries (2021)
The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: vaccinate monitor educateAnn Oncol Off J Eur Soc Med Oncol
M Tagliamento, E Agostinetto, M Bruzzone (2021)
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysisCrit Rev Oncol Hematol.
A Desai, JF Gainor, A Hegde (2021)
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsNat Rev Clin Oncol, 15
SA Madhi, V Baillie, CL Cutland (2021)
Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variantN Engl J Med
L Monin, AG Laing, M Muñoz-Ruiz (2021)
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyLancet Oncol
R Palich, M Veyri, S Marot (2021)
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patientsAnn Oncol Off J Eur Soc Med Oncol
I See, JR Su, A Lale (2021)
US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26COV2S vaccination , March 2 to April 21, 2021JAMA
I Nazy, UJ Sachs, DM Arnold (2021)
Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC subcommittee on platelet immunologyJ Thromb Haemost JTH
C Keech, G Albert, I Cho (2020)
Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccineN Engl J Med, 383
NC Kyriakidis, A López-Cortés, EV González, AB Grimaldos, EO Prado (2021)
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidatesNPJ Vacc, 6
E Korompoki, M Gavriatopoulou, DP Kontoyiannis (2021)
COVID-19 vaccines in patients with cancer-a welcome addition, but there is need for optimizationJAMA Oncol
KS Saini, K Punie, C Twelves (2021)
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeuticsExpert Opin Biol Therapy
(US CDC (2021) Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html#Coadministration. Accessed 26 May 2021.)
US CDC (2021) Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html#Coadministration. Accessed 26 May 2021.US CDC (2021) Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html#Coadministration. Accessed 26 May 2021., US CDC (2021) Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html#Coadministration. Accessed 26 May 2021.
J-X Li, F-C Zhu (2021)
Adjuvantation helps to optimise COVID-19 vaccine candidateLancet Infect Dis
KS Saini, HB de Las, J de Castro (2020)
Effect of the COVID-19 pandemic on cancer treatment and researchLancet Haematol, 7
A Pottegård, LC Lund, Ø Karlstad (2021)
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort studyBMJ, 373
(Food and Drug Administration (2021) Conduct of clinical trials of medical products during the COVID-19 public health emergency. guidance for industry, investigators, and institutional review boards. https://www.fda.gov/media/136238/download. Accessed 26 May 2021.)
Food and Drug Administration (2021) Conduct of clinical trials of medical products during the COVID-19 public health emergency. guidance for industry, investigators, and institutional review boards. https://www.fda.gov/media/136238/download. Accessed 26 May 2021.Food and Drug Administration (2021) Conduct of clinical trials of medical products during the COVID-19 public health emergency. guidance for industry, investigators, and institutional review boards. https://www.fda.gov/media/136238/download. Accessed 26 May 2021., Food and Drug Administration (2021) Conduct of clinical trials of medical products during the COVID-19 public health emergency. guidance for industry, investigators, and institutional review boards. https://www.fda.gov/media/136238/download. Accessed 26 May 2021.
B Choi, MC Choudhary, J Regan (2020)
Persistence and evolution of SARS-CoV-2 in an immunocompromised hostN Engl J Med, 383
(World Health Organization (2021). Draft landscape and tracker of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed 26 MAy 2021.)
World Health Organization (2021). Draft landscape and tracker of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed 26 MAy 2021.World Health Organization (2021). Draft landscape and tracker of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed 26 MAy 2021., World Health Organization (2021). Draft landscape and tracker of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed 26 MAy 2021.
(2021)
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B117 and B1351 VariantsN Engl J Med
SD Østergaard, M Schmidt, E Horváth-Puhó, RW Thomsen, HT Sørensen (2021)
Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?Lancet Lond Engl
E-J Lee, DB Cines, T Gernsheimer (2021)
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccinationAm J Hematol, 96
J Oldenburg, R Klamroth, F Langer (2021)
Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTHHamostaseologie
A Ribas, R Sengupta, T Locke (2021)
Priority COVID-19 vaccination for patients with cancer while vaccine supply is limitedCancer Discov, 11
M Voysey, SA Costa Clemens, SA Madhi (2021)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsLancet Lond Engl, 397
(US Food and Drug Administration. FDA News Release (2021) FDA and CDC lift recommended pause on Johnson and Johnson (Janssen) COVID-19 vaccine use following thorough safety review. https://www.fda.gov/news-events/press-announcements/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough. Accessed 26 May 2021.)
US Food and Drug Administration. FDA News Release (2021) FDA and CDC lift recommended pause on Johnson and Johnson (Janssen) COVID-19 vaccine use following thorough safety review. https://www.fda.gov/news-events/press-announcements/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough. Accessed 26 May 2021.US Food and Drug Administration. FDA News Release (2021) FDA and CDC lift recommended pause on Johnson and Johnson (Janssen) COVID-19 vaccine use following thorough safety review. https://www.fda.gov/news-events/press-announcements/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough. Accessed 26 May 2021., US Food and Drug Administration. FDA News Release (2021) FDA and CDC lift recommended pause on Johnson and Johnson (Janssen) COVID-19 vaccine use following thorough safety review. https://www.fda.gov/news-events/press-announcements/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough. Accessed 26 May 2021.
GA Poland, IG Ovsyannikova, RB Kennedy (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidatesLancet Lond Engl, 396
JK Hwang, T Zhang, AZ Wang, Z Li (2021)
COVID-19 vaccines for patients with cancer: benefits likely outweigh risksJ Hematol OncolJ Hematol Oncol, 14
(CDC Health Alert Network (2021) Cases of cerebral venous sinus thrombosis with thrombocytopenia after receipt of the Johnson and Johnson COVID-19 Vaccine. https://emergency.cdc.gov/han/2021/han00442.asp. Accessed 26 May 2021.)
CDC Health Alert Network (2021) Cases of cerebral venous sinus thrombosis with thrombocytopenia after receipt of the Johnson and Johnson COVID-19 Vaccine. https://emergency.cdc.gov/han/2021/han00442.asp. Accessed 26 May 2021.CDC Health Alert Network (2021) Cases of cerebral venous sinus thrombosis with thrombocytopenia after receipt of the Johnson and Johnson COVID-19 Vaccine. https://emergency.cdc.gov/han/2021/han00442.asp. Accessed 26 May 2021., CDC Health Alert Network (2021) Cases of cerebral venous sinus thrombosis with thrombocytopenia after receipt of the Johnson and Johnson COVID-19 Vaccine. https://emergency.cdc.gov/han/2021/han00442.asp. Accessed 26 May 2021.
(Medicines and healthcare products regulatory agency, UK (2021). Coronavirus vaccine - weekly summary of yellow card reporting. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting. Accessed 26 May 2021.)
Medicines and healthcare products regulatory agency, UK (2021). Coronavirus vaccine - weekly summary of yellow card reporting. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting. Accessed 26 May 2021.Medicines and healthcare products regulatory agency, UK (2021). Coronavirus vaccine - weekly summary of yellow card reporting. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting. Accessed 26 May 2021., Medicines and healthcare products regulatory agency, UK (2021). Coronavirus vaccine - weekly summary of yellow card reporting. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting. Accessed 26 May 2021.
W Tu, DS Gierada, BN Joe (2021)
COVID-19 vaccination-related lymphadenopathy: what to be awareRadiol Imaging Cancer, 3
AJX Lee, K Purshouse (2021)
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemicBr J Cancer
M Lambertini, A Toss, A Passaro (2019)
Cancer care during the spread of coronavirus disease (COVID-19) in Italy: young oncologists’ perspectiveESMO Open
DB Cines, JB Bussel (2021)
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopeniaN Engl J Med
HB de Las, KS Saini, F Boyle (2020)
Cancer treatment and research during the COVID-19 pandemic: experience of the first 6 monthsOncol Ther, 8
RH Shaw, A Stuart, M Greenland, X Liu, JSN Van-Tam, MD Snape (2021)
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity dataThe Lancet
C Corti, E Crimini, P Tarantino (1990)
SARS-CoV-2 vaccines for cancer patients: a call to actionEur J Cancer Oxf Engl, 2021
KM Neuzil (2021)
Interplay between emerging SARS-CoV-2 variants and pandemic controlN Engl J Med
X Wang, KK Sahu, J Cerny (2021)
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19J Thromb Thrombolysis, 51
I Meattini, P Franco, L Belgioia (2019)
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation’s young oncologistsESMO Open
E Callaway (2021)
Mix-and-match COVID vaccines trigger potent immune responseNature., 593
(Medicines and Healthcare products Regulatory Agency (2021) Press Release: MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots. https://www.gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots. Accessed 26 May 2021.)
Medicines and Healthcare products Regulatory Agency (2021) Press Release: MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots. https://www.gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots. Accessed 26 May 2021.Medicines and Healthcare products Regulatory Agency (2021) Press Release: MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots. https://www.gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots. Accessed 26 May 2021., Medicines and Healthcare products Regulatory Agency (2021) Press Release: MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots. https://www.gov.uk/government/news/mhra-issues-new-advice-concluding-a-possible-link-between-covid-19-vaccine-astrazeneca-and-extremely-rare-unlikely-to-occur-blood-clots. Accessed 26 May 2021.
KS Saini, M Tagliamento, M Lambertini (1990)
Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studiesEur J Cancer Oxf Engl, 2020
M Aapro, GH Lyman, C Bokemeyer (2021)
Supportive care in patients with cancer during the COVID-19 pandemicESMO Open, 6
KRW Emary, T Golubchik, PK Aley (2021)
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialLancet Lond Enl
Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
Oncology and Therapy – Springer Journals
Published: Dec 1, 2021
Keywords: Cancer; COVID-19; Efficacy; mRNA; SARS-CoV-2; Toxicity; Vaccine; Viral vector
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.